Goodmorning $IN $IMLFF $ $Get ready for a breakout
Post# of 49
InMed Announces Positive Pre-Clinical Data on an Ocular Hydrogel Formulation using a Biosynthesized Cannabinoid
https://www.prnewswire.com/news-releases/inme...91353.html
ALSO CONSIDER...
GW Pharmaceuticals (GWPH) successfully isolated a particular part of the marjuana plant and brought to market a multiple sclerosis treatment that’s approved for use in dozens of countries.
GW's success in developing pharmaceutical drugs from marjuana has sent its shares from less than $9 in 2013 to more than $105 today with a market value of more than $2.6 billion!!!
GW Pharma has only identified 14 or so Cannabinoids to develop therapies with and their method of extraction is time consuming and costly.
INMED, on the other hand, has a tool that can potentially identify all 90+ Cannabinoids!!
So it's no wonder why INMED Chief Medical Officer jumped ship from GW Pharmaceuticals where he previously served as an Associate Medical
Director!
MOST IMPORTANTLY DON'T FORGET TO DO YOUR OWN DD